APA (7th ed.) Citation

Hall, B., Killinger, B., Fraher, C., Martin, B., Roberts, M., Turner, J., . . . Latham, G. (2023). P477: An amplification-based, nanopore carrier screening panel resolves clinically-relevant variants in CFTR, SMN1/2, HBA1/2, HBB, and FMR1 in a unified workflow. Elsevier.

Chicago Style (17th ed.) Citation

Hall, Bradley, Bryan Killinger, Christopher Fraher, Bradley Martin, Monica Roberts, Jonathan Turner, Pranesh Rao, Ryan Routsong, and Gary Latham. P477: An Amplification-based, Nanopore Carrier Screening Panel Resolves Clinically-relevant Variants in CFTR, SMN1/2, HBA1/2, HBB, and FMR1 in a Unified Workflow. Elsevier, 2023.

MLA (9th ed.) Citation

Hall, Bradley, et al. P477: An Amplification-based, Nanopore Carrier Screening Panel Resolves Clinically-relevant Variants in CFTR, SMN1/2, HBA1/2, HBB, and FMR1 in a Unified Workflow. Elsevier, 2023.